The Union Budget 2025-26 has allocated ₹3,992.90 crore to the Ministry of AYUSH, marking a 14.15% increase from the previous year’s revised estimate of ₹3,497.64 crore. This significant boost reflects the government’s commitment to promoting traditional medicine systems, including Ayurveda, Yoga, Unani, Siddha, and Homeopathy (AYUSH).

This article provides a detailed breakdown of the allocation, key areas of investment, and the impact of this budget on the AYUSH sector.

AYUSH Budget 2025 Allocation Breakdown

The ₹3,992.90 crore allocated for AYUSH has been distributed among key initiatives aimed at strengthening research, education, and healthcare infrastructure. Here’s a closer look at how these funds will be utilized:

Increased Funding for Autonomous Bodies – ₹1,965.80 Crore

Autonomous bodies play a crucial role in research and development for AYUSH systems. The ₹1,965.80 crore budgeted for them includes the following allocations:

• Central Council for Research in Ayurvedic Sciences (CCRAS) – ₹457.20 crore
• Central Council for Research in Homoeopathy (CCRH) – ₹165 crore
• Central Council for Research in Unani Medicine (CCRUM) – ₹214.50 crore
• Central Council for Research in Siddha (CCRS) – ₹70 crore
• All India Institute of Ayurveda (AIIA), Delhi – ₹251.20 crore

This funding will be used to expand research initiatives, improve clinical trials, and modernize infrastructure at these institutions. It will also help in developing new courses, training programs, and international collaborations.

National Medicinal Plants Board (NMPB) – ₹18.59 Crore

The National Medicinal Plants Board (NMPB) plays a crucial role in ensuring a sustainable supply of medicinal plants for AYUSH medicines. The ₹18.59 crore allocated will support:

• Conservation and large-scale cultivation of medicinal plants
• Providing financial aid to farmers engaged in herbal farming
• Research on rare and endangered medicinal plant species

This move will strengthen the supply chain for Ayurvedic and other AYUSH medicines, reducing dependency on imported raw materials.

Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) – ₹21.96 Crore

To ensure standardization and quality control of AYUSH medicines, the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) has been allocated ₹21.96 crore. This will support:

✔ Establishing stricter quality control measures 

✔ Developing pharmacopoeial standards for AYUSH medicines 

✔ Serving as the appellate authority for drug testing

This allocation is expected to enhance the credibility of Indian AYUSH products in domestic and global markets.

Impact of the AYUSH Budget 2025-26

This increased budget allocation will have a far-reaching impact on various aspects of AYUSH, including:

✅ Stronger Research & Innovation: More funds will accelerate research in Ayurveda, Unani, Siddha, and Homeopathy. 

✅ Better Global Recognition: Standardization will help Indian AYUSH medicines gain international acceptance. 

✅ More Career Opportunities: Increased funding for educational institutes means better career prospects for students. 

✅ Support for Farmers & Industry Growth: Investments in medicinal plant farming will boost rural employment. 

✅ Improved Healthcare Access: More hospitals and digital initiatives will make AYUSH treatments more accessible.

Final Thoughts – The Future of AYUSH

The ₹3,992.90 crore allocation underscores the government’s commitment to AYUSH and its role in India’s healthcare system. By boosting research, standardization, and infrastructure, this budget aims to make AYUSH a trusted alternative to modern medicine.

With India moving towards an integrated healthcare model, the future of AYUSH looks bright and promising. More research, better education, and wider public awareness will further strengthen India’s position as a global leader in traditional medicine.

Want to Build a Career in AYUSH?

Explore the best AYUSH courses and career opportunities. Contact us today for expert guidance!